Glass House Brands (GLAS) Preferred Stock Liabilities (2020 - 2026)

Glass House Brands' (GLAS) quarterly Preferred Stock Liabilities came in at $77.5 million in Q1 2026, up 3018.71% year-on-year from $2.5 million in Q1 2025, and little changed on a QoQ basis from $77.5 million in Q3 2025.

Glass House Brands (GLAS) Preferred Stock Liabilities (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Preferred Stock Liabilities data on file, last reported at $77.5 million in Q1 2026.

  • On a quarterly basis, Preferred Stock Liabilities rose 3018.71% year-over-year to $77.5 million in Q1 2026; TTM through Mar 2026 was $77.5 million, a 3018.71% increase from a year earlier, with the FY2024 full-year figure at $2.6 million, down 69.91% from the prior year.
  • Preferred Stock Liabilities for Q1 2026 stood at $77.5 million, roughly flat from $77.5 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for GLAS reached as high as $77.5 million in Q3 2025 and fell as low as $2.5 million in Q1 2025.
  • Historically, Preferred Stock Liabilities has averaged $15.6 million across 5 years, with a median of $8.6 million in 2023.
  • Across the five-year window, Preferred Stock Liabilities sank 99.32% in 2022 and jumped 3018.71% in 2026, its largest moves.
  • Year by year, Preferred Stock Liabilities stood at $8.6 million in 2022, then decreased by 0.22% to $8.6 million in 2023, then tumbled by 69.91% to $2.6 million in 2024, then soared by 2905.04% to $77.5 million in 2025, then changed by 0.0% to $77.5 million in 2026.
  • Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $77.5 million in Q1 2026, $77.5 million in Q3 2025, and $15.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 77.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 77.50 Mn
Sep 30, 2025 77.50 Mn
Jun 30, 2025 15.00 Mn
Mar 31, 2025 2.49 Mn
Dec 31, 2024 2.58 Mn
Sep 30, 2024 2.98 Mn
Jun 30, 2024 5.83 Mn
Mar 31, 2024 8.58 Mn
Dec 31, 2023 8.57 Mn
Sep 30, 2023 8.56 Mn
Jun 30, 2023 8.60 Mn
Mar 31, 2023 8.60 Mn
Dec 31, 2022 8.59 Mn
Sep 30, 2022 8.23 Mn
Jun 30, 2022 2.76 Mn
Mar 31, 2022 2.76 Mn
Dec 31, 2021 2.76 Mn
Sep 30, 2021 2.76 Mn
Mar 31, 2021 402.50 Mn
Dec 31, 2020 402.50 Mn